Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Combined treatment with omalizumab and etanercept in a patient with chronic spontaneous urticaria and rheumatoid arthritis

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{e3d2f03d8017419694246a6f62267124,
title = "Combined treatment with omalizumab and etanercept in a patient with chronic spontaneous urticaria and rheumatoid arthritis",
abstract = "We present a case report of a 64-year old female patient with rheumatoid arthritis and chronic spontaneous urticaria. She was treated with a combination of etanercept and omalizumab with good results and no adverse effects. In selected patients with severe inflammatory disease activity it is worth considering combined biologic therapy. However, treatment should be closely monitored as short-term and long-term side effects are not properly elucidated.",
keywords = "Adult, Anti-Allergic Agents/therapeutic use, Antirheumatic Agents/therapeutic use, Arthritis, Rheumatoid/drug therapy, Chronic Disease, Drug Therapy, Combination, Etanercept/therapeutic use, Female, Humans, Omalizumab/therapeutic use, Urticaria/drug therapy",
author = "Ghazanfar, {Misbah Noshela} and Thomsen, {Simon Francis}",
year = "2019",
month = "6",
doi = "10.1080/09546634.2018.1515465",
language = "English",
volume = "30",
pages = "387--388",
journal = "Journal of Dermatological Treatment",
issn = "0954-6634",
publisher = "Taylor & Francis Ltd",
number = "4",

}

RIS

TY - JOUR

T1 - Combined treatment with omalizumab and etanercept in a patient with chronic spontaneous urticaria and rheumatoid arthritis

AU - Ghazanfar, Misbah Noshela

AU - Thomsen, Simon Francis

PY - 2019/6

Y1 - 2019/6

N2 - We present a case report of a 64-year old female patient with rheumatoid arthritis and chronic spontaneous urticaria. She was treated with a combination of etanercept and omalizumab with good results and no adverse effects. In selected patients with severe inflammatory disease activity it is worth considering combined biologic therapy. However, treatment should be closely monitored as short-term and long-term side effects are not properly elucidated.

AB - We present a case report of a 64-year old female patient with rheumatoid arthritis and chronic spontaneous urticaria. She was treated with a combination of etanercept and omalizumab with good results and no adverse effects. In selected patients with severe inflammatory disease activity it is worth considering combined biologic therapy. However, treatment should be closely monitored as short-term and long-term side effects are not properly elucidated.

KW - Adult

KW - Anti-Allergic Agents/therapeutic use

KW - Antirheumatic Agents/therapeutic use

KW - Arthritis, Rheumatoid/drug therapy

KW - Chronic Disease

KW - Drug Therapy, Combination

KW - Etanercept/therapeutic use

KW - Female

KW - Humans

KW - Omalizumab/therapeutic use

KW - Urticaria/drug therapy

U2 - 10.1080/09546634.2018.1515465

DO - 10.1080/09546634.2018.1515465

M3 - Journal article

VL - 30

SP - 387

EP - 388

JO - Journal of Dermatological Treatment

JF - Journal of Dermatological Treatment

SN - 0954-6634

IS - 4

ER -

ID: 59165943